These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
266 related items for PubMed ID: 9525590
1. The I domain is required for efficient plasma membrane binding of human immunodeficiency virus type 1 Pr55Gag. Sandefur S, Varthakavi V, Spearman P. J Virol; 1998 Apr; 72(4):2723-32. PubMed ID: 9525590 [Abstract] [Full Text] [Related]
2. Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag). Sandefur S, Smith RM, Varthakavi V, Spearman P. J Virol; 2000 Aug; 74(16):7238-49. PubMed ID: 10906178 [Abstract] [Full Text] [Related]
3. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. Spearman P, Wang JJ, Vander Heyden N, Ratner L. J Virol; 1994 May; 68(5):3232-42. PubMed ID: 8151785 [Abstract] [Full Text] [Related]
4. Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins. Huvent I, Hong SS, Fournier C, Gay B, Tournier J, Carrière C, Courcoul M, Vigne R, Spire B, Boulanger P. J Gen Virol; 1998 May; 79 ( Pt 5)():1069-81. PubMed ID: 9603321 [Abstract] [Full Text] [Related]
6. Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism. Spearman P, Horton R, Ratner L, Kuli-Zade I. J Virol; 1997 Sep; 71(9):6582-92. PubMed ID: 9261380 [Abstract] [Full Text] [Related]
11. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. Zhou W, Resh MD. J Virol; 1996 Dec; 70(12):8540-8. PubMed ID: 8970978 [Abstract] [Full Text] [Related]
12. Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding. Ono A, Demirov D, Freed EO. J Virol; 2000 Jun; 74(11):5142-50. PubMed ID: 10799589 [Abstract] [Full Text] [Related]
13. Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: co-encapsidation and interference with viral protease-mediated Gag processing. Bardy M, Gay B, Pébernard S, Chazal N, Courcoul M, Vigne R, Decroly E, Boulanger P. J Gen Virol; 2001 Nov; 82(Pt 11):2719-2733. PubMed ID: 11602784 [Abstract] [Full Text] [Related]
16. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly. Ono A, Orenstein JM, Freed EO. J Virol; 2000 Mar; 74(6):2855-66. PubMed ID: 10684302 [Abstract] [Full Text] [Related]
17. Human immunodeficiency virus type 1 virion density is not determined by nucleocapsid basic residues. Cimarelli A, Luban J. J Virol; 2000 Aug; 74(15):6734-40. PubMed ID: 10888611 [Abstract] [Full Text] [Related]
18. Substitution of leucine 8 in the simian immunodeficiency virus matrix protein impairs particle formation without affecting N-myristylation of the Gag precursor. González SA, Affranchino JL. Virology; 1998 Jan 05; 240(1):27-35. PubMed ID: 9448686 [Abstract] [Full Text] [Related]
19. Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor. Bouyac M, Courcoul M, Bertoia G, Baudat Y, Gabuzda D, Blanc D, Chazal N, Boulanger P, Sire J, Vigne R, Spire B. J Virol; 1997 Dec 05; 71(12):9358-65. PubMed ID: 9371595 [Abstract] [Full Text] [Related]
20. Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway. Chazal N, Gay B, Carrière C, Tournier J, Boulanger P. J Virol; 1995 Jan 05; 69(1):365-75. PubMed ID: 7983731 [Abstract] [Full Text] [Related] Page: [Next] [New Search]